HRL vs KURA · P/E 29, rev $8.96B vs rev $20.9M
Hormel Foods Corporation (HRL) versus Kura Oncology Inc (KURA) — a side-by-side from cached financials, not a winner call.
Hormel Foods Corporation (HRL) is a packaged foods company listed on NYSE.
Kura Oncology Inc (KURA) is a biotechnology company listed on NASDAQ.
Latest reported HRL revenue for 2026-07-26 was $8.96B. Net income was $398.8M. Revenue was up 49.4% from 2026-04-26 to 2026-07-26. HRL currently screens at market cap $13.39B and trailing P/E 28.6.
Latest reported KURA revenue for 2026-06-30 was $20.9M. Net income was -$68.3M. Revenue was up 14.3% from 2026-03-31 to 2026-06-30. KURA currently screens at market cap $861.1M.
HRL currently screens at market cap $13.39B and trailing P/E 28.6. KURA currently screens at market cap $861.1M.
Not investment advice. Open the HRL and KURA stock pages for the full models.
Not investment advice.